drugset / Trial / NCT01469481

Single Dose Study To Study The Absorption, Metabolism And Excretion Of PF-04991532

NCT01469481

Phase 1 Completed 6 enrolled Pfizer
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to evaluate the excretion balance, metabolic profile and the routes of excretion of \[14C\]PF-04991532 in healthy adult male subjects.

Timeline

Start
2011-11
Primary completion
2011-11
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-04991532 Small molecule 450 mg Oral

Indications

No indication recorded.